Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (11): 1070-1074.DOI: 10.3969/j.issn.1673-8640.2017.011.029
• Orginal Article • Previous Articles
ZHANG Yixin1, WEI Dianjun2, NING Li2
Received:2017-02-15
Online:2017-11-30
Published:2017-12-07
CLC Number:
ZHANG Yixin, WEI Dianjun, NING Li. Semaphorin 3A detection in the diagnosis of kidney injury[J]. Laboratory Medicine, 2017, 32(11): 1070-1074.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.011.029
| [1] | KOLODKIN A L,MATTHES D J,O'CONNOR T P,et al. Fasciclin Ⅳ:sequence,expression,and function during growth cone guidance in the grasshopper embryo[J]. Neuron,1992,9(5):831-845. |
| [2] | EPSTEIN J A,AGHAJANIAN H,SINGH M K.Semaphorin signaling in cardiovascular development[J]. Cell Metab,2015,21(2):163-173. |
| [3] | LUO Y,RAIBLE D,RAPER J A.Collapsin:a protein in brain that induces the collapse and paralysis of neuronal growth cones[J]. Cell,1993,75(2):217-227. |
| [4] | NEUFELD G,SABAG A D,RABINOVICZ N,et al.Semaphorins in angiogenesis and tumor progression[J]. Cold Spring Harb Perspect Med,2012,2(1):a006718. |
| [5] | TAKAMATSU H,KUMANOGOH A.Diverse roles for semaphorin-plexin signaling in the immune system[J]. Trends Immunol,2012,33(3):127-135. |
| [6] | CORA D,ASTANINA E,GIRAUDO E,et al.Semaphorins in cardiovascular medicine[J]. Trends Mol Med,2014,20(10):589-598. |
| [7] | JONGBLOETS B C,PASTERKAMP R J.Semaphorin signalling during development[J]. Development,2014,141(17):3292-3297. |
| [8] | VILLEGAS G,TUFRO A.Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney[J]. Mech Dev,2002,119(Suppl 1):S149-S153. |
| [9] | REIDY K J,VILLEGAS G,TEICHMAN J,et al.Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development[J]. Development,2009,136(23):3979-3989. |
| [10] | REIDY K,TUFRO A.Semaphorins in kidney development and disease:modulators of ureteric bud branching,vascular morphogenesis,and podocyte-endothelial crosstalk[J]. Pediatr Nephrol,2011,26(9):1407-1412. |
| [11] | TRAN T S,KOLODKIN A L,BHARADWAJ R.Semaphorin regulation of cellular morphology[J]. Annu Rev Cell Dev Biol,2007,23:263-292. |
| [12] | Semaphorin Nomenclature Committee.Unified nomenclature for the semaphorins/collapsins[J]. Cell,1999,97(5):551-552. |
| [13] | FEINER L,KOPPEL A M,KOBAYASHI H,et al.Secreted chick semaphorins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ[J]. Neuron,1997,19(3):539-545. |
| [14] | LIU H,JUO Z S,SHIM A H,et al.Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1[J]. Cell,2010,142(5):749-761. |
| [15] | JANSSEN B J,ROBINSON R A,PÉREZ-BRANGULI F,et al. Structural basis of semaphorin-plexin signalling[J]. Nature,2010,467(7319):1118-1122. |
| [16] | NOGI T,YASUI N,MIHARA E,et al.Structural basis for semaphorin signalling through the plexin receptor[J]. Nature,2010,467(7319):1123-1127. |
| [17] | NEGISHI M,OINUMA I,KATOH H.R-ras as a key player for signaling pathway of plexins[J]. Mol Neurobiol,2005,32(3):217-222. |
| [18] | GU C,RODRIGUEZ E R,REIMERT D V,et al.Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development[J]. Dev Cell,2003,5(1):45-57. |
| [19] | HILLMAN R T,FENG B Y,NI J,et al.Neuropilins are positive regulators of Hedgehog signal transduction[J]. Genes Dev,2011,25(22):2333-2346. |
| [20] | MUDERS M H.Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma[J]. Anticancer Agents Med Chem,2011,11(5):442-447. |
| [21] | RIZZOLIO S,TAMAGNONE L.Multifaceted role of neuropilins in cancer[J]. Curr Med Chem,2011,18(23):3563-3575. |
| [22] | OHTA K,MIZUTANI A,KAWAKAMI A,et al.Plexin:a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions[J]. Neuron,1995,14(6):1189-1199. |
| [23] | BORK P,DOERKS T,SPRINGER T A,et al.Domains in plexins:links to integrins and transcription factors[J]. Trends Biochem Sci,1999,24(7):261-263. |
| [24] | KLOSTERMANN A,LOHRUM M,ADAMS R H,et al.The chemorepulsive activity of the axonal guidance signal semaphorin D requires dimerization[J]. J Biol Chem,1998,273(13):7326-7331. |
| [25] | CHEN H,CHÉDOTAL A,HE Z,et al. Neuropilin-2,a novel member of the neuropilin family,is a high affinity receptor for the semaphorins Sema E and Sema Ⅳ but not Sema Ⅲ[J]. Neuron,1997,19(3):547-559. |
| [26] | KOLODKIN A L,LEVENGOOD D V,ROWE E G,et al.Neuropilin is a semaphorin Ⅲ receptor[J]. Cell,1997,90(4):753-762. |
| [27] | HE Z,TESSIER-LAVIGNE M.Neuropilin is a receptor for the axonal chemorepellent Semaphorin Ⅲ[J]. Cell,1997,90(4):739-751. |
| [28] | GOSHIMA Y,NAKAMURA F,STRITTMATTER P,et al.Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33[J]. Nature,1995,376(6540):509-514. |
| [29] | JAYAKUMAR C,RANGANATHAN P,DEVARAJAN P,et al.Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury[J]. PLoS One,2013,8(3):e58446. |
| [30] | VIAZZI F,RAMESH G,JAYAKUMAR C,et al.Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease:a nested case-control study[J]. J Nephrol,2015,28(3):315-320. |
| [31] | TUFRO A.Semaphorin3a signaling,podocyte shape,and glomerular disease[J]. Pediatr Nephrol,2014,29(4):751-755. |
| [32] | REIDY K J,AGGARWAL P K,JIMENEZ J J,et al.Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction[J]. Am J Pathol,2013,183(4):1156-1168. |
| [33] | RANGANATHAN P,JAYAKUMAR C,MOHAMED R,et al.Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury[J]. Am J Physiol Renal Physiol,2014,307(2):F183-F194. |
| [34] | MOHAMED R,RANGANATHAN P,JAYAKUMAR C,et al.Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice[J]. J Mol Med(Berl),2014,92(12):1245-1256. |
| [35] | DOI K,NOIRI E,NANGAKU M,et al.Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit[J]. Nephrol Dial Transplant,2014,29(1):73-80. |
| [36] | 田漫漫,赵双平. 尿Sema3A对重症监护病房患者急性肾损伤的早期诊断价值[J]. 中华医学杂志,2015,95(19):1457-1462. |
| [37] | LEWANDOWSKA L,MATUSZKIEWICZ-ROWINSKA J,JAYAKUMAR C,et al.Netrin-1 and semaphorin 3A predict the development of acute kidney injury in liver transplant patients[J]. PLoS One,2014,9(10):e107898. |
| [1] | SUN Zepeng, WANG Hongbin, WANG Jiandong, SONG Dewei, XIAO Peng. Analysis and progress of peptide and protein biomarker methodology for myocardial injury [J]. Laboratory Medicine, 2023, 38(8): 784-789. |
| [2] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
| [3] | GAO Feng. Clinical application of novel tumor biomarkers:prospects and challenges [J]. Laboratory Medicine, 2023, 38(4): 303-306. |
| [4] | ZHOU Furong, LI Yanzhu, LIU Yonggan. Application of lncRNA SNP in colorectal cancer susceptibility prediction and prognosis assessment [J]. Laboratory Medicine, 2023, 38(12): 1206-1210. |
| [5] | LU Qiyuan, LU Jianhua. Biomarker research progress for the diagnosis of periprosthetic joint infection [J]. Laboratory Medicine, 2023, 38(10): 997-1002. |
| [6] | CHEN Xuewei, LI Yirong. Candidate biomarkers in metabolic syndrome based on GEO database [J]. Laboratory Medicine, 2023, 38(1): 32-38. |
| [7] | WU Yating, LI Zhuolin, LEI Yan, JIA Ruxue, ZHANG Shenghang, WANG Shuiliang. Research progress of miRNA in urine as a biomarker for common malignant tumors [J]. Laboratory Medicine, 2023, 38(1): 94-99. |
| [8] | WANG Rui, LI Zhaoyan, ZHAO Aiguang. Application of circulating tumor DNA detection in the diagnosis and treatment of gastric cancer [J]. Laboratory Medicine, 2022, 37(9): 877-881. |
| [9] | WU Yanqian, YU Chong, SHEN Lu, ZHENG Haoran, HONG Yeting. Research progress of body fluid piRNA as a potential biomarker of disease [J]. Laboratory Medicine, 2022, 37(8): 782-786. |
| [10] | FENG Xueqing, JU Yi, LI Qing, JIN Zhonggan. Research progress of electrochemical aptasensors for the determination of biomarkers [J]. Laboratory Medicine, 2022, 37(5): 477-482. |
| [11] | HUANG Xiaofeng, FAN Xueming, YAO Tianyue, YUAN Wenhua, ZHAO Zhiyun, SONG Yunxiao. Correlation between red cell distribution width and prostate cancer [J]. Laboratory Medicine, 2021, 36(6): 590-595. |
| [12] | GAO Dongtian, LIU Lihua, SHEN Aihua, SUN Yin. Progress of IPAI experimental diagnosis [J]. Laboratory Medicine, 2021, 36(4): 453-461. |
| [13] | WANG Qianqing, HONG Juan, DU Chao, CHU Qinghua. Clinical role of serum cathepsin D determination in non-alcoholic fatty liver disease [J]. Laboratory Medicine, 2020, 35(6): 578-582. |
| [14] | MA Yingbo, CAO Wenjun. Research progress on neutrophil to lymphocyte ratio in eye diseases [J]. Laboratory Medicine, 2020, 35(5): 501-505. |
| [15] | LIU Yan, LONG Yin, PAN Weijie, ZHANG Tong, WENG Wenhao, YU Ying. Role of fecal DNA level of Fusobacterium nucleatum and clbA+ Escherichia coli in the diagnosis of colorectal cancer [J]. Laboratory Medicine, 2020, 35(4): 314-317. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||